Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.
2.

Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein.

Marcello A, Ferrari A, Pellegrini V, Pegoraro G, Lusic M, Beltram F, Giacca M.

EMBO J. 2003 May 1;22(9):2156-66.

3.

A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb.

Zhang F, Barboric M, Blackwell TK, Peterlin BM.

Genes Dev. 2003 Mar 15;17(6):748-58.

4.

The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.

Hoque M, Young TM, Lee CG, Serrero G, Mathews MB, Pe'ery T.

Mol Cell Biol. 2003 Mar;23(5):1688-702.

5.

A nucleolar TAR decoy inhibitor of HIV-1 replication.

Michienzi A, Li S, Zaia JA, Rossi JJ.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14047-52. Epub 2002 Oct 10.

6.

Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy.

Sano M, Abdellatif M, Oh H, Xie M, Bagella L, Giordano A, Michael LH, DeMayo FJ, Schneider MD.

Nat Med. 2002 Nov;8(11):1310-7. Epub 2002 Sep 30.

PMID:
12368904
8.

Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter.

Eberhardy SR, Farnham PJ.

J Biol Chem. 2002 Oct 18;277(42):40156-62. Epub 2002 Aug 9.

9.

CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization.

Napolitano G, Licciardo P, Carbone R, Majello B, Lania L.

J Cell Physiol. 2002 Aug;192(2):209-15.

PMID:
12115727
10.

Activation of MyoD-dependent transcription by cdk9/cyclin T2.

Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL, Giordano A.

Oncogene. 2002 Jun 13;21(26):4137-48.

11.
12.

Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Bourgeois CF, Kim YK, Churcher MJ, West MJ, Karn J.

Mol Cell Biol. 2002 Feb;22(4):1079-93.

14.

Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells.

Darbinian N, Sawaya BE, Khalili K, Jaffe N, Wortman B, Giordano A, Amini S.

J Neuroimmunol. 2001 Dec 3;121(1-2):3-11.

PMID:
11730934
15.

7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Nguyen VT, Kiss T, Michels AA, Bensaude O.

Nature. 2001 Nov 15;414(6861):322-5.

PMID:
11713533
16.

The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Yang Z, Zhu Q, Luo K, Zhou Q.

Nature. 2001 Nov 15;414(6861):317-22.

PMID:
11713532
17.

Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.

Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP.

J Biol Chem. 2002 Jan 25;277(4):2396-405. Epub 2001 Nov 9.

18.

Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.

Kiernan RE, Emiliani S, Nakayama K, Castro A, Labbé JC, Lorca T, Nakayama Ki K, Benkirane M.

Mol Cell Biol. 2001 Dec;21(23):7956-70.

19.

c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.

Eberhardy SR, Farnham PJ.

J Biol Chem. 2001 Dec 21;276(51):48562-71. Epub 2001 Oct 22.

20.

Supplemental Content

Support Center